X0306 4 2016-07-27 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001243004 SMITH SANDFORD D C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2016-07-27 4 M 0 2222 A 3667 D Common Stock 2016-07-27 4 F 0 777 1.55 D 2890 D Restricted Stock Units 2016-07-27 4 M 0 2222 0.00 D Common Stock 2222 8888 D Each restricted stock unit represents a contingent right to receive one share of common stock. 16.67% of the grant vested on January 27, 2016, and an additional 16.67% vested on July 27, 2016. Subject to the Reporting Person continuing to serve as a member of the board of Aegerion Pharmaceuticals, Inc., an additional 16.67% of the grant will vest on each of January 27, 2017; July 27, 2017; January 27, 2018; and August 21, 2018. /s/ Jennifer Fitzpatrick, attorney-in-fact 2016-07-29